胰蛋白酶市場－全球產業規模、佔有率、趨勢、機會、預測：按原料、應用、最終用戶、地區和競爭對手分類，2021-2031年

全球胰蛋白酶市場預計將從 2025 年的 9,976 萬美元成長到 2031 年的 1.4047 億美元，複合年成長率為 5.87%。

胰蛋白酶是絲胺酸蛋白酶，主要萃取自牲畜的胰腺，能夠將蛋白質分解成胜肽和胺基酸。在生物製藥領域，它是細胞分離、疫苗研發和胰島素生產的關鍵試劑；而在食品工業中，它有助於改善食品的質地和消化率。這一成長得益於該行業對生命科學的強烈依賴。根據生技創新組織（BIO）預測，到2024年，美國上市生技公司的營收預計將成長6.8%，達到2,050億美元，顯示強勁的資金籌措環境支撐了對胰蛋白酶等關鍵生物製程工具的需求。

儘管前景樂觀，但市場在原料採購方面仍面臨許多挑戰。依賴動物性萃取物會對供應鏈帶來風險，例如牲畜疾病和病毒污染，因此需要嚴格的法律規範。為解決這些安全問題，必須採用嚴格且成本高昂的純化製程才能達到藥品標準。因此，動物性原料採購的不穩定性以及難以保證產品無病原體，都構成了阻礙胰蛋白酶產品全球擴充性和商業性應用的重大瓶頸。

市場促進因素

生物製藥產業和疫苗生產的擴張，以及酵素在細胞培養通訊協定中的關鍵作用，是全球胰蛋白酶市場的主要驅動力。胰蛋白酶仍然是用於黏附細胞收集和組織分離的標準蛋白水解劑，而這些步驟是病毒載體和疫苗生產的關鍵步驟。隨著大型製藥公司擴大生產以對抗感染疾病，上游生物製程對高純度胰蛋白酶的需求激增。這種成長動能體現在大規模的基礎設施投資中，例如賽諾菲在2024年5月宣布投資5.86億美元在多倫多建立先進的疫苗生產設施，這將直接推動對關鍵試劑的營運需求。

此外，這種酵素在商業胰島素生產中發揮著至關重要的作用，它能將胰島素原酶促裂解為活性胰島素，進而推動市場發展。這項功能對於滿足全球日益成長的糖尿病治療需求至關重要。世界衛生組織（WHO）預測，到2024年，全球糖尿病成人患者人數將超過8億，這將對供應鏈造成巨大壓力，迫使其擴大藥品生產規模。主要生產商正透過快速擴建基礎設施來應對這項挑戰；例如，諾和諾德公司於2024年6月宣布投資41億美元，在美國建造第二座灌裝和包裝工廠。這凸顯了該公司積極拓展胰蛋白酶依賴型胰島素業務的決心。

市場挑戰

對動物性萃取物的依賴是全球胰蛋白酶市場擴充性的一大障礙。由於胰蛋白酶主要來自於豬、牛等牲畜的胰腺，其供應鏈極易受到生物風險和農業波動的影響。這種依賴性使得生產商面臨傳染病爆發導致的突發性供應中斷，進而引發原料數量限制以及對來自疫區的動物產品實施嚴格的監管禁運。

這些生物威脅導致市場不穩定。根據世界動物衛生組織（OIE）稱，2024年持續蔓延的非洲豬瘟已影響60多個國家的家豬，嚴重限制了用於胰蛋白酶提取的豬源性原料的貿易和供應。如此廣泛的疾病爆發迫使生產者實施複雜的安全措施，以確保原料不含病原體。因此，需要進行嚴格的病毒去活化和純化，從而增加了生產成本和前置作業時間。這成為限制生物製藥產業高效滿足日益成長的需求的主要瓶頸。

市場趨勢

將胰蛋白酶整合到自動化高通量蛋白質體學工作流程中，正在從根本上改變市場模式。研究機構需要能夠在大規模樣品製備中提供卓越一致性的酵素解決方案。高活性和高穩定性的胰蛋白酶對於現代分析平台至關重要，能夠確保更快、可重複且完全的蛋白質消化，這對於大規模人群健康研究至關重要。這種向大規模、高效處理的轉變正在推動對專用級試劑的採用，以支援連續運行。正如賽默飛世爾科技公司在2025年1月的新聞稿中所述，英國生物銀行藥物蛋白質體學計劃採用了他們的平台，分析了來自約60萬個檢體的5,400多種蛋白質。這一規模凸顯了高通量生物學研究對酵素試劑日益成長的需求。

此外，胰蛋白酶（一種胰臟酶）在培養肉和細胞農業領域的應用日益廣泛，預示著新的消費領域的湧現。這種酵素對於生質能收穫和維持細胞增殖過程中的細胞活力至關重要。隨著這一新興領域從試點研究走向商業化生產，大量投資正被用於最佳化生物製程並確保關鍵原料的供應鏈。這種對規模化生產的重視對於細胞衍生蛋白產品的商業性至關重要。根據良好食品研究所（Good Food Institute）2025年3月發布的報告，該領域展現出強勁的韌性，Prolific Machines公司已完成5,460萬美元的B輪資金籌措。這筆投資將用於推進依賴這些關鍵細胞培養組件的生物製造技術。

目錄

第1章概述

第2章：調查方法

第3章執行摘要

第4章：客戶心聲

第5章：全球胰蛋白酶市場展望

• 市場規模及預測
  • 按金額
• 市佔率及預測
  • 依原料分類（豬肉來源、牛來源、其他）
  • 按應用領域（生物技術/製藥業、食品業、化妝品/個人護理、廢棄物處理、其他）
  • 按最終用戶（調查、診斷、工業應用）
  • 按地區
  • 按公司（2025 年）
• 市場地圖

第6章：北美胰蛋白酶市場展望

• 市場規模及預測
• 市佔率及預測
• 北美洲：國別分析
  • 美國
  • 加拿大
  • 墨西哥

第7章：歐洲胰蛋白酶市場展望

• 市場規模及預測
• 市佔率及預測
• 歐洲：國別分析
  • 德國
  • 法國
  • 英國
  • 義大利
  • 西班牙

第8章：亞太地區胰蛋白酶市場展望

• 市場規模及預測
• 市佔率及預測
• 亞太地區：國別分析
  • 中國
  • 印度
  • 日本
  • 韓國
  • 澳洲

第9章：中東與非洲胰蛋白酶市場展望

• 市場規模及預測
• 市佔率及預測
• 中東與非洲：國別分析
  • 沙烏地阿拉伯
  • 阿拉伯聯合大公國
  • 南非

第10章：南美洲胰蛋白酶市場展望

• 市場規模及預測
• 市佔率及預測
• 南美洲：國別分析
  • 巴西
  • 哥倫比亞
  • 阿根廷

第11章 市場動態

• 促進因素
• 任務

第12章 市場趨勢與發展

• 併購
• 產品發布
• 近期趨勢

第13章：全球胰蛋白酶市場：SWOT分析

第14章：波特五力分析

• 產業競爭
• 新進入者的潛力
• 供應商的議價能力
• 顧客權力
• 替代品的威脅

第15章 競爭格局

• Merck KGaA
• Novozymes A/S, part of Novonesis Group
• Agilent Technologies, Inc.
• Thermo Fisher Scientific Inc
• Sartorius AG
• Bioseutica BV
• Biozym Scientific GmbH
• PromoCell GmbH
• Promega Corporation
• Bovogen Biologicals Pty Ltd

第16章 策略建議

第17章：關於研究公司及免責聲明

The Global Trypsin Market is projected to expand from USD 99.76 Million in 2025 to USD 140.47 Million by 2031, reflecting a CAGR of 5.87%. As a serine protease primarily extracted from the pancreas of livestock, trypsin functions by breaking down proteins into peptides and amino acids. It acts as a pivotal reagent within the biopharmaceutical sector for cell dissociation, vaccine development, and insulin manufacturing, while also enhancing texture and digestibility in the food industry. The sector's heavy dependence on life sciences fuels this growth; according to the Biotechnology Innovation Organization, revenue for U.S. public bioscience companies increased by 6.8% to $205 billion in 2024, indicating a strong funding landscape that sustains the demand for critical bioprocessing tools like trypsin.

Despite this positive outlook, the market encounters substantial obstacles regarding raw material procurement. The reliance on animal-derived extraction subjects the supply chain to risks involving livestock diseases and viral contamination, necessitating strict regulatory oversight. These safety issues require rigorous, expensive purification procedures to satisfy pharmaceutical standards. Consequently, the instability of animal sourcing and the difficulty of guaranteeing pathogen-free products generate significant bottlenecks that hinder the global scalability and commercial reach of trypsin products.

Market Driver

The expansion of the biopharmaceutical sector and vaccine production serves as a major catalyst for the Global Trypsin Market, fueled by the enzyme's essential role in cell culture protocols. Trypsin remains the standard proteolytic agent for harvesting adherent cells and tissue dissociation, a critical step in manufacturing viral vectors and vaccines. As pharmaceutical leaders ramp up production to address infectious diseases, the demand for high-grade trypsin for upstream bioprocessing has escalated. This momentum is highlighted by significant infrastructure investments, such as Sanofi's May 2024 announcement of a $586 million investment to open an advanced vaccine manufacturing facility in Toronto, which directly drives operational demand for key reagents.

Furthermore, the market is driven by the enzyme's critical role in commercial insulin manufacturing, where it is used to enzymatically cleave proinsulin into active insulin. This function is essential for addressing the growing global need for diabetes treatments. According to the World Health Organization, the number of adults with diabetes worldwide exceeded 800 million in 2024, placing immense pressure on supply chains to boost therapeutic production. Major manufacturers are responding with rapid infrastructure expansion; for example, Novo Nordisk announced a $4.1 billion investment in June 2024 to construct a second fill and finishing facility in the US, underscoring the aggressive scaling of insulin operations dependent on trypsin.

Market Challenge

The dependence on animal-derived extraction poses a significant barrier to the scalability of the Global Trypsin Market. Because trypsin is primarily sourced from the pancreas of livestock, such as pigs and cattle, the supply chain is intrinsically susceptible to biological risks and agricultural volatility. This reliance exposes manufacturers to abrupt disruptions from epizootic outbreaks, which limit raw material volumes and trigger strict regulatory embargoes on animal by-products from impacted areas.

These biological threats result in market instability. According to the World Organisation for Animal Health, the continued spread of African Swine Fever in 2024 impacted domestic swine populations in more than 60 countries, severely limiting the trade and availability of porcine materials needed for trypsin extraction. Such widespread disease prevalence compels manufacturers to implement complex safety measures to ensure pathogen-free ingredients. The consequent need for rigorous viral inactivation and purification increases production costs and lead times, creating a major bottleneck that hampers the industry's capacity to efficiently satisfy the biopharmaceutical sector's growing demand.

Market Trends

The integration of trypsin into automated high-throughput proteomics workflows is fundamentally altering the market, as research institutions require enzyme solutions capable of delivering exceptional consistency for large-scale sample preparation. Modern analytical platforms demand highly active and stable trypsin to ensure reproducible and complete protein digestion within shorter timeframes, a necessity for population-scale health research. This shift toward massive, streamlined processing drives the uptake of specialized reagent grades that support continuous operation. As noted in a January 2025 press release from Thermo Fisher Scientific, the UK Biobank Pharma Proteomics Project selected the company's platform to analyze over 5,400 proteins across roughly 600,000 samples, a scale that highlights the rising volume of enzymatic reagents required for high-throughput biological studies.

Additionally, the rising application of trypsin in cultivated meat and cellular agriculture marks a growing frontier for consumption, where the enzyme is essential for harvesting biomass and maintaining cell viability during expansion. As this emerging sector moves from pilot research to commercial manufacturing, significant investment is being focused on optimizing bioprocesses and securing supply chains for key inputs. This emphasis on scaling is crucial for making cell-based protein products commercially accessible. According to The Good Food Institute's March 2025 report, the sector showed resilience with Prolific Machines securing a $54.6 million Series B funding round, an investment dedicated to advancing biomanufacturing technologies that depend on these critical cell culture components.

Key Market Players

• Merck KGaA
• Novozymes A/S, part of Novonesis Group
• Agilent Technologies, Inc.
• Thermo Fisher Scientific Inc
• Sartorius AG
• Bioseutica BV
• Biozym Scientific GmbH
• PromoCell GmbH
• Promega Corporation
• Bovogen Biologicals Pty Ltd

Report Scope

In this report, the Global Trypsin Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Trypsin Market, By Source

• Porcine
• Bovine
• Others

Trypsin Market, By Application

• Biotechnology and Pharmaceutical Industry
• Food Industry
• Cosmetics and Personal Care
• Waste Treatment
• Others

Trypsin Market, By End User

• Research
• Diagnostics
• Industrial use

Trypsin Market, By Region

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
• Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Trypsin Market.

Available Customizations:

Global Trypsin Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Trypsin Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Source (Porcine, Bovine, Others)
  • 5.2.2. By Application (Biotechnology and Pharmaceutical Industry, Food Industry, Cosmetics and Personal Care, Waste Treatment, Others)
  • 5.2.3. By End User (Research, Diagnostics, Industrial use)
  • 5.2.4. By Region
  • 5.2.5. By Company (2025)
• 5.3. Market Map

6. North America Trypsin Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Source
  • 6.2.2. By Application
  • 6.2.3. By End User
  • 6.2.4. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Trypsin Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Source
      • 6.3.1.2.2. By Application
      • 6.3.1.2.3. By End User
  • 6.3.2. Canada Trypsin Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Source
      • 6.3.2.2.2. By Application
      • 6.3.2.2.3. By End User
  • 6.3.3. Mexico Trypsin Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Source
      • 6.3.3.2.2. By Application
      • 6.3.3.2.3. By End User

7. Europe Trypsin Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Source
  • 7.2.2. By Application
  • 7.2.3. By End User
  • 7.2.4. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. Germany Trypsin Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Source
      • 7.3.1.2.2. By Application
      • 7.3.1.2.3. By End User
  • 7.3.2. France Trypsin Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Source
      • 7.3.2.2.2. By Application
      • 7.3.2.2.3. By End User
  • 7.3.3. United Kingdom Trypsin Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Source
      • 7.3.3.2.2. By Application
      • 7.3.3.2.3. By End User
  • 7.3.4. Italy Trypsin Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Source
      • 7.3.4.2.2. By Application
      • 7.3.4.2.3. By End User
  • 7.3.5. Spain Trypsin Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Source
      • 7.3.5.2.2. By Application
      • 7.3.5.2.3. By End User

8. Asia Pacific Trypsin Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Source
  • 8.2.2. By Application
  • 8.2.3. By End User
  • 8.2.4. By Country
• 8.3. Asia Pacific: Country Analysis
  • 8.3.1. China Trypsin Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Source
      • 8.3.1.2.2. By Application
      • 8.3.1.2.3. By End User
  • 8.3.2. India Trypsin Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Source
      • 8.3.2.2.2. By Application
      • 8.3.2.2.3. By End User
  • 8.3.3. Japan Trypsin Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Source
      • 8.3.3.2.2. By Application
      • 8.3.3.2.3. By End User
  • 8.3.4. South Korea Trypsin Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Source
      • 8.3.4.2.2. By Application
      • 8.3.4.2.3. By End User
  • 8.3.5. Australia Trypsin Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Source
      • 8.3.5.2.2. By Application
      • 8.3.5.2.3. By End User

9. Middle East & Africa Trypsin Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Source
  • 9.2.2. By Application
  • 9.2.3. By End User
  • 9.2.4. By Country
• 9.3. Middle East & Africa: Country Analysis
  • 9.3.1. Saudi Arabia Trypsin Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Source
      • 9.3.1.2.2. By Application
      • 9.3.1.2.3. By End User
  • 9.3.2. UAE Trypsin Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Source
      • 9.3.2.2.2. By Application
      • 9.3.2.2.3. By End User
  • 9.3.3. South Africa Trypsin Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Source
      • 9.3.3.2.2. By Application
      • 9.3.3.2.3. By End User

10. South America Trypsin Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Source
  • 10.2.2. By Application
  • 10.2.3. By End User
  • 10.2.4. By Country
• 10.3. South America: Country Analysis
  • 10.3.1. Brazil Trypsin Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Source
      • 10.3.1.2.2. By Application
      • 10.3.1.2.3. By End User
  • 10.3.2. Colombia Trypsin Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Source
      • 10.3.2.2.2. By Application
      • 10.3.2.2.3. By End User
  • 10.3.3. Argentina Trypsin Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Source
      • 10.3.3.2.2. By Application
      • 10.3.3.2.3. By End User

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Merger & Acquisition (If Any)
• 12.2. Product Launches (If Any)
• 12.3. Recent Developments

13. Global Trypsin Market: SWOT Analysis

14. Porter's Five Forces Analysis

• 14.1. Competition in the Industry
• 14.2. Potential of New Entrants
• 14.3. Power of Suppliers
• 14.4. Power of Customers
• 14.5. Threat of Substitute Products

15. Competitive Landscape

• 15.1. Merck KGaA
  • 15.1.1. Business Overview
  • 15.1.2. Products & Services
  • 15.1.3. Recent Developments
  • 15.1.4. Key Personnel
  • 15.1.5. SWOT Analysis
• 15.2. Novozymes A/S, part of Novonesis Group
• 15.3. Agilent Technologies, Inc.
• 15.4. Thermo Fisher Scientific Inc
• 15.5. Sartorius AG
• 15.6. Bioseutica BV
• 15.7. Biozym Scientific GmbH
• 15.8. PromoCell GmbH
• 15.9. Promega Corporation
• 15.10. Bovogen Biologicals Pty Ltd

16. Strategic Recommendations

17. About Us & Disclaimer